Substrate synthesis for the asymmetric hydrogenation route to Pregabalin

ORGN 110

Tung V. Le, Pfizer Global Research and Development, Groton, CT 06340
Ethyl-3-cyano-5 methyl-hex-3-enoate, a key intermediate for the asymmetric hydrogenation route to pregabalin is obtained by a three-step process using cheap starting materials. Step 1 is a Baylis-Hillman reaction, step 2 is an acylation, and step 3 is a palladium-catalyzed carbonylation. Various issues were encountered at all steps during scale-up of process from laboratory to pilot plant. The identification of these issues, the challenges to solve the problems will be presented.